US offers 30 Billion US dollars more market to domestic pharma cos Medical Dialogues Bureau30 Jan 2020 9:40 AM GMTMumbai : Domestic pharma companies have the potential to grow their revenue from the US by almost five times at around USD 30 billion from USD 6.5...
Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer Ruby Khatun Khatun3 Sep 2018 5:00 AM GMTMumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new...